FinnCap restated their corporate rating on shares of ANGLE (LON:AGL) in a research note published on Thursday.
Shares of ANGLE stock opened at GBX 48.50 ($0.68) on Thursday. ANGLE has a 1 year low of GBX 32.27 ($0.45) and a 1 year high of GBX 80 ($1.12).
ILLEGAL ACTIVITY WARNING: “ANGLE (AGL) Rating Reiterated by FinnCap” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/04/09/angle-agl-rating-reiterated-by-finncap.html.
ANGLE Company Profile
ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.